Bladder cancer treatments are hampered by high recurrence, requiring multiple therapeutic interventions which are highly invasive and cause side effects, underscoring the need for innovative treatments. In the pursuit of advancing bladder cancer treatment, immuno-oncology shows promise. This blog delves into the importance of identifying antigens in the development of targeted cancer therapies.  

Ubiquitination plays a key role in the pathophysiology of multiple myeloma, highlighting its promise as a therapeutic target for this plasma cell malignancy. In this blog, we used Causaly to explore genetic alterations affecting by ubiquitination in multiple myeloma.

Pharmacogenomics is an emerging field that combines pharmacology and genomics to identify genetic factors influencing individual responses to medications. This innovative approach opens doors to more effective and personalized therapies, promoting patient safety and providing tailored treatment options.

In all areas of biomedicine, it is crucial for researchers to stay up to date and informed of developments in their respective field of study. Nowhere is this more important than in the field of cancer research, which consistently tops the annual charts of research-spend and subsequent volumes of research-output.